These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 26916007)

  • 1. Hsp90: A Global Regulator of the Genotype-to-Phenotype Map in Cancers.
    Jarosz D
    Adv Cancer Res; 2016; 129():225-47. PubMed ID: 26916007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. It's not magic - Hsp90 and its effects on genetic and epigenetic variation.
    Zabinsky RA; Mason GA; Queitsch C; Jarosz DF
    Semin Cell Dev Biol; 2019 Apr; 88():21-35. PubMed ID: 29807130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein folding sculpting evolutionary change.
    Lindquist S
    Cold Spring Harb Symp Quant Biol; 2009; 74():103-8. PubMed ID: 20375316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HSP90 empowers evolution of resistance to hormonal therapy in human breast cancer models.
    Whitesell L; Santagata S; Mendillo ML; Lin NU; Proia DA; Lindquist S
    Proc Natl Acad Sci U S A; 2014 Dec; 111(51):18297-302. PubMed ID: 25489079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hsp90 and complex birth defects: A plausible mechanism for the interaction of genes and environment.
    Zohn IE
    Neurosci Lett; 2020 Jan; 716():134680. PubMed ID: 31821846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Under cover: causes, effects and implications of Hsp90-mediated genetic capacitance.
    Sangster TA; Lindquist S; Queitsch C
    Bioessays; 2004 Apr; 26(4):348-62. PubMed ID: 15057933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hsp90 as a "Chaperone" of the Epigenome: Insights and Opportunities for Cancer Therapy.
    Isaacs JS
    Adv Cancer Res; 2016; 129():107-40. PubMed ID: 26916003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hsp90 as a capacitor for morphological evolution.
    Rutherford SL; Lindquist S
    Nature; 1998 Nov; 396(6709):336-42. PubMed ID: 9845070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Hsp90 molecular chaperone: an open and shut case for treatment.
    Pearl LH; Prodromou C; Workman P
    Biochem J; 2008 Mar; 410(3):439-53. PubMed ID: 18290764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene expression regulation by heat-shock proteins: the cardinal roles of HSF1 and Hsp90.
    Mazaira GI; Daneri-Becerra C; Zgajnar NR; Lotufo CM; Galigniana MD
    Biochem Soc Trans; 2018 Feb; 46(1):51-65. PubMed ID: 29273620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular mechanisms of canalization: Hsp90 and beyond.
    Salathia N; Queitsch C
    J Biosci; 2007 Apr; 32(3):457-63. PubMed ID: 17536165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined HSP90 and kinase inhibitor therapy: Insights from The Cancer Genome Atlas.
    Schwartz H; Scroggins B; Zuehlke A; Kijima T; Beebe K; Mishra A; Neckers L; Prince T
    Cell Stress Chaperones; 2015 Sep; 20(5):729-41. PubMed ID: 26070366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modularity and intrinsic evolvability of Hsp90-buffered change.
    Carey CC; Gorman KF; Rutherford S
    PLoS One; 2006 Dec; 1(1):e76. PubMed ID: 17183708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The evolution of fungal drug resistance: modulating the trajectory from genotype to phenotype.
    Cowen LE
    Nat Rev Microbiol; 2008 Mar; 6(3):187-98. PubMed ID: 18246082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The opportunities and challenges of personalized genome-based molecular therapies for cancer: targets, technologies, and molecular chaperones.
    Workman P
    Cancer Chemother Pharmacol; 2003 Jul; 52 Suppl 1():S45-56. PubMed ID: 12819933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The stress response: implications for the clinical development of hsp90 inhibitors.
    Whitesell L; Bagatell R; Falsey R
    Curr Cancer Drug Targets; 2003 Oct; 3(5):349-58. PubMed ID: 14529386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modifiers of the Genotype-Phenotype Map: Hsp90 and Beyond.
    Schell R; Mullis M; Ehrenreich IM
    PLoS Biol; 2016 Nov; 14(11):e2001015. PubMed ID: 27832066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hsp70 and Hsp90--a relay team for protein folding.
    Wegele H; Müller L; Buchner J
    Rev Physiol Biochem Pharmacol; 2004; 151():1-44. PubMed ID: 14740253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolutionary capacitance as a general feature of complex gene networks.
    Bergman A; Siegal ML
    Nature; 2003 Jul; 424(6948):549-52. PubMed ID: 12891357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HSP90 Molecular Chaperones, Metabolic Rewiring, and Epigenetics: Impact on Tumor Progression and Perspective for Anticancer Therapy.
    Condelli V; Crispo F; Pietrafesa M; Lettini G; Matassa DS; Esposito F; Landriscina M; Maddalena F
    Cells; 2019 Jun; 8(6):. PubMed ID: 31163702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.